v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net loss $ (3,362) $ (2,617)
Adjustments:    
Depreciation expense 2 1
Stock-based compensation 302 238
Change in fair value of derivative warrant liabilities 487 (1,395)
Deferred income tax benefit 0 (724)
Changes in operating assets and liabilities:    
Receivables 106 326
Prepaid expenses (47) (339)
Trade and other payables 711 914
Net cash used in operating activities (1,801) (3,596)
Cash flows from investing activities:    
Purchase of short-term investments 0 (15)
Net cash used in investing activities 0 (15)
Cash flows from financing activities:    
Payment of stock issuance costs (327) 0
Net cash used in financing activities (327) 0
Net decrease in cash and cash equivalents (2,128) (3,611)
Cash and cash equivalents, beginning of period 22,133 23,005
Cash and cash equivalents, end of period 20,005 19,394
Cash and cash equivalents are comprised of:    
Cash 1,918 3,041
Cash equivalents $ 18,087 $ 16,353